Amanta Healthcare Files for IPO, Plans to Raise Funds for Expansion

30 Sep 2024 , 10:02 AM

Ahmedabad-based pharmaceutical company Amanta Healthcare has filed a draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (SEBI), signaling its intention to raise funds through an initial public offering (IPO).

The IPO will consist entirely of a fresh issue of 1.25 crore equity shares by the company.

The funds raised through the IPO will be utilized for setting up a new manufacturing line for SteriPort at Kheda, Gujarat, and purchasing equipment for a new manufacturing line for small volume parenteral at the same plant. The remaining funds will be used for general corporate purposes.

Company Profile:

• Products: Amanta Healthcare specializes in manufacturing sterile liquid products, medical devices, and other pharmaceutical formulations.
• Therapeutic Areas: The company’s products are used in fluid therapy, ophthalmic care, respiratory care, and irrigation solutions.
• Registrations: Amanta has a strong presence with 113 active product registrations with international authorities.

Financial Performance:

• Revenue: Amanta’s revenue increased by 8.2% to ₹280.3 crore in the fiscal year ended March 2024.
• Profitability: The company turned profitable in the fiscal year 2024, reporting a net profit of ₹3.62 crore compared to a loss of ₹2.11 crore in the previous year.